当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析

君实生物-U

(688180)

  

流通市值:239.80亿  总市值:321.25亿
流通股本:7.66亿   总股本:10.27亿

君实生物-U(688180)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年年度实现净利润-10.09亿元,每股收益-0.87元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年年度最新股东权益605659.43万元,未分配利润-1121616.75万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年年度最新总资产1238232.69万元,负债632573.26万元。

利润表
报告期2025-12-312025-09-302025-06-302025-03-31
营业总收入2,498,420,333.971,805,880,133.521,168,383,949.66500,591,459.94
营业总成本3,444,363,178.982,473,163,074.831,659,107,714.05782,539,195.35
其他经营收益
营业利润-999,463,383.92-671,058,241.61-475,011,078.54-281,715,865.28
利润总额-1,023,274,342.07-692,393,121.41-485,211,590.12-286,837,114.51
净利润-1,009,393,410.45-674,309,869.11-465,673,412.19-259,586,438.78
每股收益
其他综合收益-6,750,254.67-146,608.69-15,916,155.46-10,204,644.58
综合收益总额-1,016,143,665.12-674,456,477.8-481,589,567.65-269,791,083.36
资产负债表
报告期2025-12-312025-09-302025-06-302025-03-31
流动资产:
流动资产合计4,457,703,511.074,445,064,264.394,784,755,600.844,255,015,311.22
非流动资产:
非流动资产合计7,924,623,384.297,242,977,370.966,890,832,474.916,642,054,455.58
资产总计12,382,326,895.3611,688,041,635.3511,675,588,075.7510,897,069,766.8
流动负债:
流动负债合计2,778,278,033.832,748,630,846.132,968,737,939.933,044,658,054.06
非流动负债:
非流动负债合计3,547,454,580.762,644,091,377.342,314,733,583.042,183,251,649.14
负债合计6,325,732,614.595,392,722,223.475,283,471,522.975,227,909,703.2
所有者权益(或股东权益):
归属于母公司股东权益合计6,030,434,432.076,216,157,386.496,372,334,459.95,620,244,628.63
股东权益合计6,056,594,280.776,295,319,411.886,392,116,552.785,669,160,063.6
负债和股东权益合计12,382,326,895.3611,688,041,635.3511,675,588,075.7510,897,069,766.8
现金流量表
报告期2025-12-312025-09-302025-06-302025-03-31
经营活动产生的现金流量:
经营活动现金流入小计2,841,283,482.042,139,612,068.291,404,458,148.66803,419,825.51
经营活动现金流出小计3,360,851,214.362,483,022,336.461,733,846,482827,751,022.01
经营活动产生的现金流量净额-519,567,732.32-343,410,268.17-329,388,333.34-24,331,196.5
投资活动产生的现金流量:
投资活动现金流入小计2,325,262,549.21,718,649,206.71,207,614,304.91490,394,088.86
投资活动现金流出小计3,905,973,432.422,627,438,852.341,760,468,211.27832,019,803.48
投资活动产生的现金流量净额-1,580,710,883.22-908,789,645.64-552,853,906.36-341,625,714.62
筹资活动产生的现金流量:
筹资活动现金流入小计4,764,723,517.23,533,008,134.162,640,106,775.131,422,331,063.18
筹资活动现金流出小计2,535,417,774.791,990,436,816.31,255,742,433.161,035,553,067.93
筹资活动产生的现金流量净额2,229,305,742.411,542,571,317.861,384,364,341.97386,777,995.25
汇率变动对现金及现金等价物的影响-21,706,525.95-7,377,820.48376,249.04-791,648.43
现金及现金等价物净增加额107,320,600.92282,993,583.57502,498,351.3120,029,435.7
期末现金及现金等价物余额2,593,999,709.742,769,672,692.392,989,177,460.132,506,708,544.52
补充资料:
现金及现金等价物的净增加额107,320,600.92-502,498,351.31-
最新报告期:2026-01-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中邮证券盛丽华-0.150.14--2026-01-06
TOP↑